Corporate and brand identities of Graphy and the world's first direct 3D-printable Shape Memory Aligner® - a game-changer in digital orthodontics.

Volunteering while traveling might sound like a modern trend, but for many, it’s become the most fulfilling way to see the ...

Vivasure Medical announced today that it received CE mark approval for its PerQseal Elite vascular closure system.

Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.

Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE ...

The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

“The CE Mark approval for Optune Lua for metastatic non-small cell lung cancer is a significant milestone in Novocure’s efforts to improve outcomes for people living with aggressive cancers ...

Novocure (NVCR) announced that Optune Lua has received a CE Mark for the treatment of adult patients with metastatic non-small cell lung cancer ...

The data from the Phase III LUNAR trial, which assessed the device’s treatment efficacy and safety, supported the approval.